Value of animal models. Lessons learnt from another therapeutic area: implications for respiratory disease Source: Annual Congress 2007 - PG11 - Translation of animal models to human airway disease Year: 2007
Features of asthma management: quantifying the patient‘s perspective using discrete choice modelling Source: Eur Respir J 2006; 28: Suppl. 50, 122s Year: 2006
The limitations of quantitative measures: assessing approaches to research into NIV use in MND Source: Annual Congress 2009 - New trends in noninvasive ventilation for chronic respiratory failure Year: 2009
Observational studies assessing the pharmacological treatment of obstructive lung disease: strengths, challenges and considerations for study design Source: ERJ Open Res, 6 (4) 00044-2020; 10.1183/23120541.00044-2020 Year: 2020
Multidimensional assessment methods for dyspnoea profiling in clinical practice and laboratory research Source: International Congress 2018 – Dyspnoea: a multidimensional and multidisciplinary approach Year: 2018
Implications of the exposome and its applicability in clinical and epidemiological studies Source: International Congress 2016 – Genetics, epigenetics and the exposome Year: 2016
COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness Source: Eur Respir J, 56 (2) 2002135; 10.1183/13993003.02135-2020 Year: 2020
Clinical trial landscape for M/XDR-TB: current evidence and future perspectives Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis Year: 2019
Innovative realistic training phantom for all aspects of diagnostic and therapeutic bronchoscopy Source: Virtual Congress 2020 – Evaluation of knowledge transfer into clinical practice Year: 2020
What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement Source: Eur Respir J, 52 (5) 1801261; 10.1183/13993003.01261-2018 Year: 2018
(Non-)sense to interpret meta-analyses with heterogeneous interventions: the example of non-pharmacological interventions Source: International Congress 2015 – How to perform and interpret systematic reviews and meta-analyses Year: 2015
Respiratory monitoring: revisiting classical physiological principles with new tools Source: Eur Respir J 2004; 24 : 718-719 Year: 2004
Clinical exercise testing with reference to lung diseases: indications, standardization and interpretation strategies Source: Guideline 1997 Year: 1997
Lung function trajectory research: historical perspective and future prospects Source: Research Seminar 2021 – Lung function trajectories from birth to death, health and disease, and pre-war to today Year: 2021
Missing data in IPF trials: do not let methodological issues undermine a major therapeutic breakthrough Source: Eur Respir J 2015; 46: 607-614 Year: 2015
Is poor asthma self-management due to failure to recognise symptoms or failure to act? Novel insights from mining large-scale clinical observational study Source: International Congress 2019 – M-health/e-health II Year: 2019
Where do we stand with asthma phenotypes derived from data-driven methods? A systematic review Source: International Congress 2019 – Respiratory function assessment in disease Year: 2019
Revising our approach to conducting therapeutic clinical research in COPD Source: Eur Respir J, 51 (2) 1702712; 10.1183/13993003.02712-2017 Year: 2018